15.02.2022 19:02:19

DGAP-PVR: Heidelberg Pharma AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

DGAP Voting Rights Announcement: Heidelberg Pharma AG
Heidelberg Pharma AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

15.02.2022 / 19:02
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Notification of Major Holdings

1. Details of issuer
Name: Heidelberg Pharma AG
Street: Gregor-Mendel-Str. 22
Postal code: 68526
City: Ladenburg
Germany
Legal Entity Identifier (LEI): 391200E09XYBYITR1W32

2. Reason for notification
  Acquisition/disposal of shares with voting rights
X Acquisition/disposal of instruments
  Change of breakdown of voting rights
X Other reason:
Conclusion of a pool agreement

3. Details of person subject to the notification obligation
Natural person (first name, surname): Mathias Hothum
Date of birth: 09 Apr 1967

4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
dievini Hopp BioTech holding GmbH & Co. KG
DH-LT-Investments GmbH

5. Date on which threshold was crossed or reached:
10 Feb 2022

6. Total positions
  % of voting rights attached to shares
(total of 7.a.)		 % of voting rights through instruments
(total of 7.b.1 + 7.b.2)		 Total of both in %
(7.a. + 7.b.)		 Total number of voting rights pursuant to Sec. 41 WpHG
New 28.69 % 1.33 % 28.69 % 34175809
Previous notification n/a % n/a % n/a % /

7. Details on total positions
a. Voting rights attached to shares (Sec. 33, 34 WpHG)
ISIN Absolute In %
  Direct
(Sec. 33 WpHG)		 Indirect
(Sec. 34 WpHG)		 Direct
(Sec. 33 WpHG)		 Indirect
(Sec. 34 WpHG)
DE000A11QVV0 0 9803357 0.00 % 28.69 %
Total 9803357 28.69 %

b.1. Instruments according to Sec. 38 (1) no. 1 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in %
0 0.00 %
    Total 0 0.00 %

b.2. Instruments according to Sec. 38 (1) no. 2 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in %
Share transfer agreement n/a n/a n/a 453761 1.33 %
      Total 453761 1.33 %

8. Information in relation to the person subject to the notification obligation
  Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.).
X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Name % of voting rights (if at least 3% or more) % of voting rights through instruments (if at least 5% or more) Total of both (if at least 5% or more)
-Herr Mathias Hothum % % %
-MH-LT-Investments GmbH 28.69 % % 28.69 %

9. In case of proxy voting according to Sec. 34 para. 3 WpHG
(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)

Date of general meeting:
Holding total positions after general meeting (6.) after annual general meeting:
Proportion of voting rights Proportion of instruments Total of both
% % %

10. Other explanatory remarks:
Accession of MH-LT-Investments GmbH to the pool agreement between dievini Hopp BioTech holding GmbH & Co. KG and DH-LT-Investments GmbH. The instruments specified under 7.b.2 relate to voting rights shares which are already attributed to MH-LT-Investments GmbH by joining the pool agreement (7.a); therefore, no addition is made under 6. (Total voting rights) no addition of the sum 7.a + 7.b.  

Date
15 Feb 2022


15.02.2022 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
Language: English
Company: Heidelberg Pharma AG
Gregor-Mendel-Str. 22
68526 Ladenburg
Germany
Internet: www.heidelberg-pharma.com

 
End of News DGAP News Service

1280922  15.02.2022 

fncls.ssp?fn=show_t_gif&application_id=1280922&application_name=news&site_id=smarthouse
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!

Nachrichten zu Heidelberg Pharma AGmehr Nachrichten

Analysen zu Heidelberg Pharma AGmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Newssuche

GO

Aktien in diesem Artikel

Heidelberg Pharma AG 2,56 5,35% Heidelberg Pharma AG

Börse aktuell - Live Ticker

ATX im Plus -- DAX leichter -- Asiens Börsen folgen schwachen US-Vorgaben
Der heimische Aktienmarkt verbucht zum Wochenstart Gewinne. Der deutsche Leitindex gibt derweil nach. In Asien notieren die Börsen am Montag im Minus.

Nachrichten

Aktien ATX  DAX  EuroStoxx 50  Dow Jones  NASDAQ 100  Nikkei 225  S&P 500 

Kontakt  - Impressum - Werbung

Sitemap  - Datenschutz  - Disclaimer  - AGB  - Privatsphäre-Einstellungen